Warning letter
DSAART, LLC. dba Alpha Aesthetics: warning letter of Nov 24, 2021
FDA warning letter 618157 · Center for Devices and Radiological Health
Key facts
| Reference number | 618157 |
|---|---|
| Company | DSAART, LLC. dba Alpha Aesthetics |
| Subject | CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated |
| Issue date | Nov 24, 2021 |
| Posted date | Dec 28, 2021 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 803.50(a)(2), 820, 803.20(a)(3), 803.17(a)(3), 803.3, 803, 803.50(a)(1) |
| Inspection city | Carson City |
| Inspection ZIP | 89706 |
| Inspection start date | Jul 19, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: